Genotoxicity assessment of the antimalarial compound artesunate in somatic cells of mice

Food and Chemical Toxicology

Volumn 49, Issue 6, 2011, Pages 1335-1339

  Aquino, Ivani ^a   Perazzo, Fábio Ferreira ^b   Maistro, Edson Luis ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Artemisinin derivate; Artesunate; Clastogenicity; Comet assay; Micronucleus test

Indexed keywords

ARTESUNATE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA DAMAGE; ERYTHROCYTE COUNT; GENOTOXICITY; IN VIVO STUDY; LIVER CELL; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; SOMATIC CELL;

ARTESUNATE; MUS;

EID: 79955652743     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2011.03.016     Document Type: Article

References (33)

1. Angus B.J., Thaiaporn I., Chanthapadith K., Suputtamongkol Y., White N.J. Oral artesunate dose-response relationship in acute Falciparum malaria. Antimicrob. Agents Chemother. 2002, 46:778-782.
2. Brossi A., Venugopalan B., Dominguez G.L., Yeh H.J.C., Flippen-Anderson J.L., Buchs P., Luo X.D., Milhous W., Peters W. Arteether, a new antimalarial drug: synthesis and antimalarial properties. J. Med. Chem. 1988, 31:645.
3. Cai X., You P., Cai J., Yang X., Chen Q., Huang F. ART-induced biophysical and biochemical alterations of Jurkat cell membrane. Micron 2011, 42:17-28.
4. Chandra S., Chauhan L.K.S., Dhawan A., Murthy R.C., Gupta S.K. In vivo genotoxic effects of industrial waste leachates in mice following oral exposure. Environ. Mol. Mutag. 2006, 47:325-333.
5. Chen H., Shi L., Yang X., Li S., Guo X., Pan L. Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells. Int. J. Hematol. 2010, 92:587-597.
6. Dhingra V.K., Rao V., Narasu L.M. Current status of artemisinin and its derivates as antimalarial drugs. Life Sci. 2000, 66:279-300.
7. Du J.H., Zhang H.D., Ma Z.J., Ji K.M. Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemother. Pharmacol. 2010, 65:895-902.
8. Efferth T., Sauerbrey A., Olbrich A., Gebhart E., Rauch P., Weber H.O., Hengstler J.G., Halatsch M.E., Volm M., Tew K.D., Ross D.D., Funk J.O. Molecular modes of action of artesunate in tumor cell lines. Mol. Pharmacol. 2003, 64:382-394.
9. Efferth T., Giaisi M., Merling A., Krammer P.H., Weber M.L. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One 2007, 2:693.
10. Gollapudi B.B., McFadden L.G. Sample size for the estimation of polychromatic to normochromatic erythrocyte ratio in the bone marrow micronucleus test. Mut. Res. 1995, 347:97-99.
11. Hartmann A., Speit G. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol. Lett. 1997, 90:183-188.
12. Hou J., Wang D., Zhang R., Wang H. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin. Cancer Res. 2008, 14:5519-5530.
13. Klayman D.L. Qinqhaosu (Artemisinin): an antimalarial drug from China. Science 1985, 228:1049-1055.
14. Krishna G., Hayashi M. In vivo rodent micronucleus assay: protocol, conduct and data interpretation. Mutat. Res. 2000, 455:155-166.
15. Li P.C., Lam E., Roos W.P., Zdzienicka M.Z., Kaina B., Efferth T. Artesunate derived from traditional chinese medicine induces DNA damage and repair. Cancer Res. 2008, 68:4347-4351.
16. Luxemburguer C., Nosten F., Raimond S.D., Chongsuphajaisiddhi T., White N.J. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am. J. Trop. Med. Hyg. 1995, 53:522-525.
17. Meshnick S.R., Taylor T.E., Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 1996, 60:301-315.
18. Nosten F., Luxemburguer C., ter Kuile F., Woodrow C., Eh J.P., Chongsuphajaisiddhi T., White N.J. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J. Infect. Dis. 1994, 170:971-977.
19. Nosten F., Van Yugt M., Price R.N., Luxemburguer C., Thway K.L., Brockman A., ter Kuile F., Looareesuwan S., White N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. The Lancet 2000, 356:297-302.
20. Olliaro P. Mode of action and mechanism of resistance for antimalarial drug. Pharmacol. Therap. 2001, 89:207-219.
21. Price R.N., Nosten F., Luxemburguer C., Kham A., Brockman A., Chongsuphajaisiddhi T., White N.J. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:523-527.
22. Rodeiro I., Cancino L., Gonzàlez J.E., Morffi J., Garrido G., Gonzàlez R.M., Nuñez A., Delgado R. Evaluation of the genotoxic potential of Mangifera indica L. extract (Vimang), a new natural product with antioxidant activity. Food Chem. Toxicol. 2006, 44:1707-1713.
23. Schmid W. The micronucleus test. Mut. Res. 1975, 31:9-15.
24. Serpeloni J.M., Reis M.B., Rodrigues J., Santos L.C., Vilegas W., Varanda E.A., Dokkedal A.L., Colus I.M. In vivo assessment of DNA damage and protective effects of extracts from Miconia species using the comet assay and micronucleus test. Mutagenesis 2008, 23:501-507.
25. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
26. Sokal R.R., Rohlf F.J. Biometry 1995, 175-205. San Francisco, 404-486. W.H. Freeman (Ed.).
27. Speit G., Hartmann A. The Comet Assay (Single-Cell Gel Test). In: Methods in Molecular Biology, DNA Repair Protocols: Eukaryotic Systems (Henderson DS, ed.). Humana Press Inc., Totowa 1999, 113:203-212.
28. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
29. Vasquez M.Z. Combining the in vivo comet and micronucleus assays: a practical approach to genotoxicity testing and data interpretation. Mutagenesis 2010, 25:187-199.
30. WHO (World Health Organization), 2001. Malaria. Disponível em: <>Access in June, 03, 2008. http://www.rbm.who.int/cmc_upload/0/000/015/367/RBMInfosheet_6.htm.
31. WHO (World Health Organization), 2004. Handbook - Non Clinical Safety Testing. Disponível em: <>Access in Nov., 03, 2009. http://www.who.int/tdr/publications/publications/safety-handbook.htm.
32. WHO (World Health Organization) 2001. Handbook: Good Laboratory Practice (GLP). Quality practices for regulated non-clinical research and development. Disponível em: <>Access in: May, 10, 2009. http://apps.who.int/tdr/publications/training-guideline-publications/good-laboratory-practicehandbook/pdf/glp-handbook.pdf.
33. Woodrow C.J., Haynes R.K., Krishna S. Artemisinins. Postgrad. Med. J. 2005, 81:71-78.